BTSG Relative Valuation
BTSG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BTSG is overvalued; if below, it's undervalued.
Historical Valuation
Brightspring Health Services Inc (BTSG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 21.98 is considered Undervalued compared with the five-year average of 23.17. The fair price of Brightspring Health Services Inc (BTSG) is between 20.57 to 30.32 according to relative valuation methord. Compared to the current price of 19.87 USD , Brightspring Health Services Inc is Undervalued By 3.38%.
Relative Value
Fair Zone
20.57-30.32
Current Price：19.87
3.38%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.08
P/B
Median3y
1.77
Median5y
1.77
3.62
FCF Yield
Median3y
1.70
Median5y
1.70
Competitors Valuation Multiple
The average P/S ratio for BTSG's competitors is 1.97, providing a benchmark for relative valuation. Brightspring Health Services Inc Corp (BTSG) exhibits a P/S ratio of 0.28, which is -85.87% above the industry average. Given its robust revenue growth of 25.92%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Brightspring Health Services Inc (BTSG) currently overvalued or undervalued?
What is Brightspring Health Services Inc (BTSG) fair value?
How does BTSG's valuation metrics compare to the industry average?
What is the current P/B ratio for Brightspring Health Services Inc (BTSG) as of Jul 18 2025?
What is the current FCF Yield for Brightspring Health Services Inc (BTSG) as of Jul 18 2025?
What is the current Forward P/E ratio for Brightspring Health Services Inc (BTSG) as of Jul 18 2025?